These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

696 related articles for article (PubMed ID: 3672070)

  • 21. Hyperthyroidism in Europe: clinical and laboratory data of a prospective multicentric survey.
    Reinwein D; Benker G; König MP; Pinchera A; Schatz H; Schleusener H
    J Endocrinol Invest; 1986; 9 Suppl 2():1-36. PubMed ID: 2875092
    [No Abstract]   [Full Text] [Related]  

  • 22. The risk factors for malignancy in surgically treated patients for Graves' disease, toxic multinodular goiter, and toxic adenoma.
    Senyurek Giles Y; Tunca F; Boztepe H; Kapran Y; Terzioglu T; Tezelman S
    Surgery; 2008 Dec; 144(6):1028-36; discussion 1036-7. PubMed ID: 19041014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Symptomatology of Graves' disease and Plummer's disease in relation to age and thyroid hormone level.
    Tak PP; Hermans J; Haak A
    Neth J Med; 1993 Jun; 42(5-6):157-62. PubMed ID: 8377872
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyperthyroidism due to Graves' disease and due to autonomous goiter.
    Schicha H; Emrich D; Schreivogel I
    J Endocrinol Invest; 1985 Oct; 8(5):399-407. PubMed ID: 3841136
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunogenic and non-immunogenic hyperthyroidism. Recent trends in prealpine Switzerland and in coastal Poland.
    Als C; Listewnik M; Rösler H; Bartkowiak E
    Nuklearmedizin; 1995 Jun; 34(3):92-9. PubMed ID: 7630748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical value of the determination of TSH-binding inhibitory immunoglobulins (TBII) by a radioreceptor assay].
    Heberling HJ; Bierwolf B; Lohmann D
    Dtsch Z Verdau Stoffwechselkr; 1986; 46(5):301-6. PubMed ID: 2879721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidemiology of thyroid diseases in iodine sufficiency.
    Lind P; Langsteger W; Molnar M; Gallowitsch HJ; Mikosch P; Gomez I
    Thyroid; 1998 Dec; 8(12):1179-83. PubMed ID: 9920375
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hyperthyroidism and carcinoma of the thyroid gland].
    Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
    Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thyroid autoimmunity and thyroid autonomy.
    Vitti P; Mariotti S; Marcocci C; Chiovato L; Giachetti M; Fenzi G; Pinchera A
    Acta Med Austriaca; 1990; 17 Suppl 1():90-2. PubMed ID: 2202187
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.
    Sayinalp S; Akalin S; Sayinalp N; Erbaş T; Bayraktar M; Ozcebe OI; Dündar S; Kirazli S
    Horm Metab Res; 1996 Mar; 28(3):133-7. PubMed ID: 8926012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Adjuvant lithium improves the efficacy of radioactive iodine treatment in Graves' and toxic nodular disease.
    Martin NM; Patel M; Nijher GM; Misra S; Murphy E; Meeran K
    Clin Endocrinol (Oxf); 2012 Oct; 77(4):621-7. PubMed ID: 22443227
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relevance of cause of hyperthyroidism in determining its management.
    Veneman TF; Weymer M; Tjabbes T; van Haeften TW
    Neth J Med; 1989 Dec; 35(5-6):303-8. PubMed ID: 2635287
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Beta-2-microglobulin in hyperthyroidism].
    Foscolo G; Roiter I; De Menis E; Legovini P; Conte N
    Minerva Endocrinol; 1992; 17(1):1-5. PubMed ID: 1495449
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thyroid cancer in patients with hyperthyroidism.
    Pazaitou-Panayiotou K; Michalakis K; Paschke R
    Horm Metab Res; 2012 Apr; 44(4):255-62. PubMed ID: 22334393
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hyperthyroidism in older patients].
    Brun R; Jenny M; Junod JP
    Schweiz Med Wochenschr; 1978 Sep; 108(39):1504-10. PubMed ID: 581312
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chronology of Graves' ophthalmopathy in an incidence cohort.
    Bartley GB; Fatourechi V; Kadrmas EF; Jacobsen SJ; Ilstrup DM; Garrity JA; Gorman CA
    Am J Ophthalmol; 1996 Apr; 121(4):426-34. PubMed ID: 8604736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence rate and clinical features of hyperthyroidism in a long-term iodine sufficient area of Sweden (Gothenburg) 2003-2005.
    Nyström HF; Jansson S; Berg G
    Clin Endocrinol (Oxf); 2013 May; 78(5):768-76. PubMed ID: 23421407
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unusual events preceding hyperthyroidism with diffuse goiter.
    Bendezu R; Wieland RG; Tang P; Levine B
    Arch Intern Med; 1977 Aug; 137(8):1023-5. PubMed ID: 577670
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epidemiology of functional autonomy.
    Bauch K
    Exp Clin Endocrinol Diabetes; 1998; 106 Suppl 4():S16-22. PubMed ID: 9867190
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detection of TSH-binding inhibiting immunoglobulins in patients with Graves' disease and non toxic goiter.
    Mossetti G; Salomone Megna A; Lanzano C; Maddaloni D; Leonello D; Gravina E
    Boll Ist Sieroter Milan; 1986; 65(4):277-82. PubMed ID: 2878674
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 35.